Weei/nesn Jimmy Fund Radio-telethon

The legendary Ray Bourque joins, donates $10,000 to the Jimmy Fund!

ESPN's Sean McDonough joins, doubles down on his Mookie Betts comments

Robert Haddad, Chief, Division of Head and Neck Oncology, Dana-Farber Dr. Haddad received his MD Degree from St. Joseph University French School ofMedicine in Beirut. He completed his residency in internal medicine at St Luke's RooseveltMedical Center in New York City, and completed a fellowship in hematology oncology at theUniversity of Maryland Cancer Center in Baltimore.

Jigar Raythatha (Ray-tha-tha), 46, glioma, Lexington, with Kinnary (wife) and Patrick Wen, MD, Director, Center for Neuro-Oncology, Dana-Farber After two weeks of an unresolved headache, Jigar’s doctor ordered an urgent brain MRI,which revealed some abnormal findings. To get a definitive diagnosis, doctors would need toaccess his brain, so Jigar opted for a biopsy over a craniotomy. The results found he hadIDH-mutant astrocytoma, a biomarker for patients with glioma; these findings would guide theapproach to his brain surgery.· For treatment post-surgery, he takes one pill daily as an IDH inhibitor. Jigar will take thiswhile waiting for a new targeted therapy to be approved and finalized: it’s designed specificallyto target the mutation that is causing his type of cancer. At Dana-Farber, he appreciates howeveryone recognizes that you’re going through something very hard and always meets youwhere you are in your emotional journey.· For work, Jigar is the former CEO of a pharmaceutical company that focused on d

Sean Flaherty from Keches Law joins, talks about "Keches Cares" campaign

Governor Healy joins, talks about trying to bring down the cost of living in Massachusetts

Michael Casey, APRN-BC, FN, Nurse Practitioner, Gastrointestinal Oncology, Dana-Farber Michael Casey, APRN-BC, FNP is a nurse practitioner in Gastrointestinal Oncology atDana-Farber Cancer Institute. He is also the director of the Advanced Practice Nursingdepartment and co-chair of Dana-Farber’s Ethics Committee, as well as a member of theAmerican Association of Nurse Practitioners.· He earned his bachelor’s degree in biological sciences from the University of Rochesterin 1998 and his master’s degree in nursing science from Boston College in 2002. He came toDana-Farber in 2009 and has worked here ever since.· Michael’s favorite part of working at Dana-Farber is the privilege and intimacy ofcontributing to individuals’ and their families’ well-being during what is in many cases thebiggest challenge of their lives. He also appreciates the strong sense of community within theinstitution and is “humbled to share a workplace with so many colleagues who demonstrate thecommitment and impulse to care for other human

Christine Duncan, MD, Medical Director of Clinical Research and Clinical Development, Gene Therapy Program, Boston Children's Hospital Med school in Chicago; Internship and Residency at Boston Children's Hospital; PediatricHematology/Oncology Fellowship at DFCI; just celebrated being at the Farber for 20 years.· Director of Clinical Research and Development, Dana-Farber/Boston Children's Cancerand Blood Disorders Center.· Research and clinical focus on cellular therapies for rare pediatric diseases- especiallyneuro-metabolic disease and brain tumors.· Clinical leader in partnership with local biotech company (bluebird bio) and MGH in theresearch that lead to the first FDA approved therapy for children with cerebraladrenoleukodystrophy (ALD) in the world. Cerebral ALD is a progressive neurologicallydevastating disease that affects boys and ultimately leads to their deaths if not treated early.· Leader in multiple international pediatric stem cell transplant groups.· On the personal side: mom of three young boy

Dana Mohrlein, 35, astrocytoma, Niantic CT, with David Reardon, MD Clinical Director, Center of Neuro-Oncology, Dana-Farber In college, Dana thought she may have vertigo because of all her headaches, but after aseizure at her first security job, she learned she needed emergency brain surgery. After surgeryat her local hospital, she pursued a second opinion at Dana-Farber and has continued herjourney from there since. She had two additional brain surgeries that same summer atBrigham-Women's Hospital. Shortly after, she started high dose radiation locally, in partnershipwith Dana-Farber, and did 11 months of oral chemotherapy.· After treatment, 11 years passed until Dana had a recurrence last spring and underwenta fourth brain surgery. She now takes an inhibitor drug called Tibsovo, a medication specific toher mutation, that requires her to take two pills every day. The drug was released around thetime of Dana’s most recent recurrence, and she expresses it will hopefully be her “miraclemedicine” for the rest of

Martha Young, Program Manager, Pediatric Patient and Family Education, Dana-Farber Martha Young is the Program Manager for Patient and Family Education in the Jimmy FundClinic. As part of this role, she often works with the nursing team to create educationalmaterials for newly diagnosed families. She also oversees the Blum Pediatric Resource Room, aspace that integrates patient education into the everyday family experience in the Jimmy FundClinic. Throughout her 17 years in the clinic, she has worked with the team to create programsand resources aimed to help support patients and their families throughout treatment. Some ofthose programs include Music Therapy, BEADS and BEADS for Sibs, caregiver corner, artprogramming, FACES and FLASHES – groups for teen and “tween” patients to meet outside of

Shelby Young, 49, breast cancer, Orrington ME, with Kristina Worcester, RN, Breast Oncology Nurse Navigator Shelby has been having mammograms every 6 months for the past 2 years because ofdense breast tissue. In March 2022, the mammogram looked suspicious, so she had anultrasound later that day. A biopsy two weeks later confirmed that she had triple negative rightbreast cancer. She started treatment at Dana-Farber, once a week for 8 weeks, then once every3 weeks until April of 2023. Throughout that process, Shelby had a lumpectomy in September of2022 and a month of radiation in December.· Before the lumpectomy, Shelby’s surgeon placed a bead where the tumor had been, andafter removing the tissue around the bead area, the area came back negative for breast cancer.She is no longer in treatment. Shelby has had immense support from family and friends; as theTeam Mom for her daughter’s travel softball team, the support from all the girls has given herso much encouragement.· She works as a Registered Nurse in the E

Joe Castiglione and Will Fleming were joined by MLB Umpire Phil Cuzzi to discuss his journey to becoming an umpire, the pitch clock, being diagnosed with prostate cancer and quickly returning to baseball.

Jon Goff, Sales Operation Manager for Volkswagen joins the guys from the booth to discuss his company's work with the Jimmy Fund. 

Jason Hayes, District Manager of the Sherwin Williams Company, announces the company is donating $10,000 to this year's Jimmy Fund Radio Telethon live from the WEEI Sox booth!

Sarah Shields, Marketing Manager of the Prudential Center, joins Joe and Will to explain what you can expect to find at the Pru live from the WEEI Sox booth!

As a cast member/chef on the television series “America’s Test Kitchen,” and host of its companion podcast “The Walk-In,” Elle Simone Scott delights in sharing her expertise and recipes. The Boston-based celebrity chef and food stylist is also a role model, as founder and president of SheChef, Inc., a professional networking organization for fellow women chefs of color seeking success in the food and beverage, media, and hospitality industries. Elle found a new doctor once she arrived in Boston, got another ultrasound, and learned she had a cyst with cancerous concerns on her right ovary. Her doctor referred her to Dr. Michael Muto at Dana-Farber Brigham Cancer Center and was diagnosed with stage I ovarian cancer. She had surgery to remove the right ovary and fallopian tubes, alongside chemotherapy. Elle went into remission for about 5 years until it came back in 2020 as recurrent ovarian cancer in her bowel and lower bladder. She went through more surgery and chemotherapy, and is now on an immunotherapy clin

Dodgers' Manager Dave Roberts discusses his battle with cancer with Joe Castiglione.

Astros' Manager Dusty Baker sits down with Joe Castiglione to discuss his battle with cancer.

An emotional Alex Cora joins Joe Castiglione to discuss the importance of the Jimmy Fund

John F. Donohue is Chief Executive Officer of the Arbella Insurance Group andChairman of the Arbella Insurance Foundation. He is one of the founders of Arbella and has been Chairman of the Board of Directors since the company’s creation in 1988 and chairs the boards of each of the subsidiary companies. He is responsible for the strategic planning and corporate policy for all of the companies of the Arbella Insurance Group – a leader in the New England property/casualty insurance industry - as well as the strategic planning and giving initiatives for the Arbella Insurance Foundation. Since its inception in 2005, the Foundation has donated more than $40 million to charities across New England. The Arbella Insurance Group is proud to be the presenting sponsor of the WEEI/NESN Jimmy Fund Radio-Telethon again. This year marks the 15th year that Arbella has been the Presenting sponsor of the radio telethon. We are proud to support all the work Dana-Farber does to fight Cancer.